| Benjamen David Poitra, LPCC | |
|
1300 Hospital Loop, Belcourt, ND 58316 | |
| (701) 477-6111 | |
| (701) 477-2509 |
| Full Name | Benjamen David Poitra |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 1300 Hospital Loop, Belcourt, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841632528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 684-5-1-11-256 (North Dakota) | Secondary |
| 101YP2500X | Counselor - Professional | 684-5-1-11-256 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Benjamen David Poitra, LPCC 1300 Hospital Loop, Belcourt, ND 58316-9112 Ph: (701) 477-6111 | Benjamen David Poitra, LPCC 1300 Hospital Loop, Belcourt, ND 58316 Ph: (701) 477-6111 |
News Archive
Saint Louis University Center for Vaccine Development researchers have identified a potential new target for vaccines that activates a part of the immune system not previously known to be protective against Chagas disease, tuberculosis and AIDS, as well as other diseases.
Scientists at the Institute of Bioengineering and Nanotechnology (IBN) have invented an injectable and biodegradable gel that can deliver drugs at targeted sites or act as a scaffold for tissue repair.
Immunotherapy drugs that target a protein called programmed death ligand 1 (PD-L1) on the surface of cancer cells have quickly become a mainstay to treat many forms of cancer, often with dramatic results. But exactly how cancer cells turn on this protein was not completely understood.
Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Giora Weisz, M.D., Director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of medicine at Columbia University College of Physicians and Surgeons, New York, N.Y. will present his personal experience using the CorPath 200 System as part of the CorPath PRECISE Trial during a scientific presentation "Cath Lab of the Future: Robotics" at the Cardiovascular Research Technologies' annual meeting, CRT2012.
Is screening or treatment for prostate cancer the reason for decreased mortality in the USA, compared to the UK?
› Verified 5 days ago
Mrs. Juliette Marie Cain, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1105 Sheldon Souray Avenue, Belcourt, ND 58316 Phone: 701-477-3121 Fax: 701-477-8925 |